Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib. [electronic resource]
Producer: 20180601Description: 149-158 p. digitalISSN:- 1878-5875
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Arsenic Trioxide
- Arsenicals -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm
- Drug Synergism
- Gene Expression Regulation -- drug effects
- Humans
- Inhibitor of Apoptosis Proteins -- genetics
- Myeloid Cell Leukemia Sequence 1 Protein -- genetics
- Oxides -- pharmacology
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Purines -- pharmacology
- Quinazolinones -- pharmacology
- Survivin
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.